sec filing
AL
NASDAQ · ALKS
Alkermes plc
Healthcare · Biotechnology
$40.79
Up+$0.06 (+0.15%)
Updated Sep 25, 2026, 11:36 PM
SID Score
6.4/10
Composite research score
Smart Money
62/100
Neutral
- Market cap
- 4.97B
- P/E ratio
- 20.51
- Dividend yield
- 0.00%
- 52-week range
- $27.00 – $55.67
- Volume
- 2.84M
- Avg. volume
- 1.92M
Price performance
ALKS price history
1M range · 20 trading sessions · Daily adjusted prices
ALKS closed at $40.79 after 20 trading sessions, down 16.58% for the selected period.
- Last close
- $40.79
- Period change
- -16.58%
- Period low
- $40.79
- Period high
- $48.90
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 24, 2026 | $42.55 | $42.55 | $40.59 | $40.79 | 2.84M |
| Sep 23, 2026 | $43.20 | $43.62 | $41.23 | $42.13 | 2.48M |
| Sep 22, 2026 | $44.39 | $44.53 | $43.08 | $43.29 | 2.31M |
| Sep 21, 2026 | $44.27 | $44.79 | $43.11 | $44.18 | 3.73M |
| Sep 18, 2026 | $46.51 | $46.53 | $43.27 | $43.39 | 6.94M |
| Sep 17, 2026 | $47.10 | $47.397 | $46.41 | $46.71 | 1.42M |
| Sep 16, 2026 | $46.64 | $47.26 | $45.785 | $46.07 | 1.85M |
| Sep 15, 2026 | $45.73 | $46.14 | $44.63 | $46.03 | 2.15M |
| Sep 14, 2026 | $46.60 | $46.60 | $45.66 | $45.83 | 2.03M |
| Sep 11, 2026 | $46.75 | $46.75 | $45.73 | $45.97 | 1.28M |
| Sep 10, 2026 | $44.98 | $46.11 | $44.75 | $46.11 | 1.19M |
| Sep 9, 2026 | $45.24 | $45.605 | $44.72 | $45.40 | 1.44M |
| Sep 8, 2026 | $45.20 | $46.53 | $44.63 | $45.49 | 1.36M |
| Sep 4, 2026 | $46.14 | $46.93 | $45.80 | $46.10 | 1.06M |
| Sep 3, 2026 | $48.01 | $48.29 | $46.71 | $46.88 | 974.51K |
| Sep 2, 2026 | $47.70 | $48.735 | $46.68 | $47.72 | 1.57M |
| Sep 1, 2026 | $47.00 | $47.335 | $46.65 | $47.20 | 1.35M |
| Aug 31, 2026 | $47.25 | $47.56 | $46.46 | $46.99 | 1.44M |
| Aug 28, 2026 | $48.82 | $48.82 | $47.2501 | $47.41 | 1.43M |
| Aug 27, 2026 | $48.72 | $49.33 | $48.10 | $48.90 | 2.12M |
Latest ALKS news
The latest Smart Investors Daily articles mentioning ALKS.
Stock researchCompany · Forecast
Loading stock research…